查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1370917

組織學與細胞學市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會與預測，按檢查類型、按產品、按應用、按地區、按競爭細分

Histology and Cytology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type of Examination, By Product, By Application, By Region, By Competition
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022年全球組織學和細胞學市場估值達到157.4億美元，預計將以14.67%的年複合成長率（CAGR）強勁成長，預計到2028年將達到311.6億美元。細胞學和組織學是生命科學，專注於生物體中細胞、組織及其微觀解剖結構、功能和理解。這些領域有助於理解動植物組織和細胞，特別是在微觀層面上，有助於各種應用。

主要市場促進因素

癌症盛行率增加

市場概況
預測期 2024-2028
2022 年市場規模 157.4億美元
2028 年市場規模 311.6億美元
2023-2028 年年複合成長率 12.15%
成長最快的細分市場 細胞學
最大的市場 北美洲

癌症盛行率的上升極大地影響了全球組織學和細胞學市場的成長。組織學和細胞學在診斷癌症和在細胞層面上了解各種疾病方面發揮著至關重要的作用。隨著癌症病例數量的增加，對準確診斷技術的需求變得至關重要。這些技術透過在顯微鏡下檢查組織樣本和細胞來幫助診斷不同類型的癌症。隨著癌症篩檢和診斷的增加，對組織學和細胞學服務和設備的需求也隨之增加。

不斷增加的研發活動

研究與開發 (R&D) 努力推動組織學和細胞學創新，提高診斷和研究過程的準確性和可靠性。透過研發開發的先進成像技術、自動化解決方案和數位病理系統透過提供改進的診斷能力來促進市場成長。研發活動的重點是提高診斷準確性並開發新的染色方法、分子標記和成像技術，從而實現更準確的診斷並推動對這些服務的需求。

專注個人化醫療

在個人化醫療的背景下，對組織學和細胞學服務的需求增加，個人化醫療依賴分子診斷來分析遺傳和分子資訊。這些技術有助於識別特定的基因突變和改變，指導治療決策並促進市場成長。組織學和細胞學為根據患者獨特的疾病特徵制定治療策略提供了重要訊息，從而推動了對這些技術的需求。

主要市場挑戰

技術複雜性與成本

先進的組織學和細胞學技術通常需要在設備、軟體和培訓方面進行大量投資，這可能會為資源有限的機構帶來障礙。維護成本和與現有系統的整合挑戰也會阻礙技術的採用。

實驗室勞動力短缺

熟練的實驗室專業人員的短缺可能會導致診斷和報告測試結果的延遲，從而影響患者護理和創新。勞動力短缺可能會限制研究、開發和新技術採用的能力。

主要市場趨勢

液體活體組織切片和循環生物標記

分析體液中生物標記的液體活體組織切片的出現增加了對組織學和細胞學服務的需求。這些活體組織切片可以實現早期疾病檢測，並需要透過傳統的組織學和細胞學方法進行驗證。

多組學方法

在多個層面研究疾病的多組學方法同時增強了對組織學和細胞學的需求。這些技術提供了對疾病機制的全面見解，組織學和細胞學驗證了多組學資料的發現。

細分市場洞察

考試類型

由於其在早期疾病檢測中的作用，細胞學領域預計將大幅成長。巴氏抹片和細針穿刺等技術有助於識別異常的細胞變化，從而及時進行干涉並改善患者的治療結果。

應用

藥物發現和設計領域佔據市場主導地位，因為組織學和細胞學對於驗證藥物標靶、評估藥物安全性和實現個人化醫療至關重要。這些技術提供了對分子相互作用和組織特異性效應的見解。

區域洞察

北美因其先進的醫療保健系統、研究機構和監管框架而引領市場。研究工作的集中和明確的監管環境鼓勵創新和技術的採用，推動市場成長。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球組織學與細胞學市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按檢查類型（組織學、細胞學）
    • 依產品（儀器和分析軟體系統、耗材和試劑）
    • 按應用（藥物發現與設計、臨床診斷、研究）
    • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
    • 按公司分類 (2022)
  • 市場地圖
    • 按考試類型
    • 按產品分類
    • 按應用
    • 按地區

第 6 章：北美組織學與細胞學市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按檢查類型（組織學、細胞學）
    • 依產品（儀器和分析軟體系統、耗材和試劑）
    • 按應用（藥物發現與設計、臨床診斷、研究）
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲組織學與細胞學市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按檢查類型（組織學、細胞學）
    • 依產品（儀器和分析軟體系統、耗材和試劑）
    • 按應用（藥物發現與設計、臨床診斷、研究）
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區組織學與細胞學市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按檢查類型（組織學、細胞學）
    • 依產品（儀器和分析軟體系統、耗材和試劑）
    • 按應用（藥物發現與設計、臨床診斷、研究）
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲組織學與細胞學市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按檢查類型（組織學、細胞學）
    • 依產品（儀器和分析軟體系統、耗材和試劑）
    • 按應用（藥物發現與設計、臨床診斷、研究）
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲組織學和細胞學市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按檢查類型（組織學、細胞學）
    • 依產品（儀器和分析軟體系統、耗材和試劑）
    • 按應用（藥物發現與設計、臨床診斷、研究）
    • 按國家/地區
  • MEA：國家分析
    • 南非組織學和細胞學
    • 沙烏地阿拉伯組織學和細胞學
    • 阿拉伯聯合大公國組織學和細胞學

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球組織學與細胞學市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
  • SWOT分析
    • Hologic, Inc.
    • F Hoffmann-La Roche AG.
    • Abbott Laboratories Inc.
    • Becton Dickinson & Co.
    • Danaher Corporation.
    • Merck KGaA.
    • Thermo Fisher Scientific, Inc.
    • Sysmex Corporation.
    • Trivitron Healthcare.
    • Koninklijke Philips NV

第 16 章：策略建議

簡介目錄
Product Code: 15913

The Global Histology and Cytology Market reached a valuation of USD 15.74 billion in 2022 and is expected to experience robust growth with a Compound Annual Growth Rate (CAGR) of 14.67% and expected to reach USD 31.16 Billion by 2028. Cytology and histology are branches of life science that focus on the structure, function, and understanding of cells, tissues, and their microscopic anatomy in living organisms. These fields contribute to the comprehension of animal and plant tissues and cells, particularly at the microscopic level, aiding in various applications.

Key Market Drivers

Increase in Cancer Prevalence

Market Overview
Forecast Period2024-2028
Market Size 2022USD 15.74 Billion
Market Size 2028USD 31.16 Billion
CAGR 2023-202812.15%
Fastest Growing SegmentCytology
Largest MarketNorth America

The rising prevalence of cancer significantly impacts the growth of the Global Histology and Cytology Market. Histology and cytology play a crucial role in diagnosing cancer and understanding various diseases at the cellular level. With the increasing number of cancer cases, the demand for accurate diagnostic techniques becomes vital. These techniques assist in diagnosing different types of cancers by examining tissue samples and cells under a microscope. As cancer screening and diagnostics increase, the demand for histology and cytology services and equipment also rises.

Growing Research and Development Activities

Research and development (R&D) efforts drive innovation in histology and cytology, enhancing the accuracy and reliability of diagnostic and research processes. Advanced imaging techniques, automation solutions, and digital pathology systems developed through R&D contribute to the market growth by offering improved diagnostic capabilities. R&D activities focus on improving diagnostic accuracy and developing new staining methods, molecular markers, and imaging technologies, which lead to more accurate diagnoses and drive demand for these services.

Focus on Personalized Medicine

The demand for histology and cytology services increases in the context of personalized medicine, which relies on molecular diagnostics to analyze genetic and molecular information. These techniques aid in identifying specific genetic mutations and alterations, guiding treatment decisions and contributing to market growth. Histology and cytology provide essential information for tailoring treatment strategies based on a patient's unique disease characteristics, driving demand for these techniques.

Key Market Challenges

Technological Complexity and Costs

Advanced histology and cytology technologies often require significant investments in equipment, software, and training, which can pose barriers for institutions with limited resources. Maintenance costs and integration challenges with existing systems can also hinder technology adoption.

Laboratory Workforce Shortages

A shortage of skilled laboratory professionals can lead to delays in diagnosing and reporting test results, impacting patient care and innovation. Workforce shortages can limit the capacity for research, development, and the adoption of new technologies.

Key Market Trends

Liquid Biopsies and Circulating Biomarkers

The emergence of liquid biopsies, which analyze biomarkers in bodily fluids, contributes to the demand for histology and cytology services. These biopsies enable early disease detection and require validation through traditional histological and cytological methods.

Multi-Omics Approaches

Multi-omics approaches that study diseases at multiple levels simultaneously enhance the demand for histology and cytology. These techniques provide comprehensive insights into disease mechanisms, and histology and cytology validate findings from multi-omics data.

Segmental Insights

Type of Examination

The cytology segment is expected to witness substantial growth due to its role in early disease detection. Techniques like Pap smears and fine-needle aspirations aid in identifying abnormal cellular changes, leading to timely interventions and improved patient outcomes.

Application

The Drug Discovery & Designing segment dominates the market as histology and cytology are crucial for validating drug targets, assessing drug safety, and enabling personalized medicine. These techniques provide insights into molecular interactions and tissue-specific effects.

Regional Insights

North America leads the market due to its advanced healthcare systems, research institutions, and regulatory framework. The concentration of research efforts and a clear regulatory environment encourage innovation and technology adoption, driving market growth.

Key Market Players

  • Hologic, Inc.
  • F Hoffmann-La Roche AG.
  • Abbott Laboratories Inc.
  • Becton Dickinson & Co.
  • Danaher Corporation.
  • Merck KGaA.
  • Thermo Fisher Scientific, Inc.
  • Sysmex Corporation.
  • Trivitron Healthcare.
  • Koninklijke Philips N.V.

Report Scope:

In this report, the Global Histology and Cytology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

Histology and Cytology Market, By Type of Examination:

  • Histology
  • Cytology

Histology and Cytology Market, By Product:

  • Instruments and Analysis Software System
  • Consumable and Reagents

Histology and Cytology Market, By Application:

  • Drug Discovery & Designing
  • Clinical Diagnostics
  • Research

Histology and Cytology Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Histology and Cytology Market.

Available Customizations:

  • Global Histology and Cytology market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Histology and Cytology Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type Of Examination (Histology, Cytology)
    • 5.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
    • 5.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Type of Examination
    • 5.3.2 By Product
    • 5.3.3 By Application
    • 5.3.4 By Region

6. North America Histology and Cytology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type Of Examination (Histology, Cytology)
    • 6.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
    • 6.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Histology and Cytology Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type of Examination
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Histology and Cytology Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type of Examination
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Histology and Cytology Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type of Examination
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Application

7. Europe Histology and Cytology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type Of Examination (Histology, Cytology)
    • 7.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
    • 7.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Histology and Cytology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Examination
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Application
    • 7.3.2. Germany Histology and Cytology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Examination
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Histology and Cytology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Examination
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Histology and Cytology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of Examination
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Histology and Cytology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of Examination
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Application

8. Asia-Pacific Histology and Cytology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type Of Examination (Histology, Cytology)
    • 8.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
    • 8.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Histology and Cytology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Examination
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Application
    • 8.3.2. India Histology and Cytology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Examination
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Histology and Cytology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Examination
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Histology and Cytology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Examination
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Histology and Cytology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Examination
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Application

9. South America Histology and Cytology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type Of Examination (Histology, Cytology)
    • 9.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
    • 9.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Histology and Cytology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Examination
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Application
    • 9.3.2. Argentina Histology and Cytology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Examination
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Application
    • 9.3.3. Colombia Histology and Cytology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Examination
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Application

10. Middle East and Africa Histology and Cytology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type Of Examination (Histology, Cytology)
    • 10.2.2. By Product (Instruments and Analysis Software System, Consumable and Reagents)
    • 10.2.3. By Application (Drug Discovery & Designing, Clinical Diagnostics, Research)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Histology and Cytology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Examination
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Application
    • 10.3.2. Saudi Arabia Histology and Cytology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Drug Type
        • 10.3.2.2.2. By Type of Examination
        • 10.3.2.2.3. By Product
        • 10.3.2.2.4. By Application
    • 10.3.3. UAE Histology and Cytology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Examination
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Histology And Cytology Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 Hologic, Inc.
    • 15.6.2 F Hoffmann-La Roche AG.
    • 15.6.3 Abbott Laboratories Inc.
    • 15.6.4 Becton Dickinson & Co.
    • 15.6.5 Danaher Corporation.
    • 15.6.6 Merck KGaA.
    • 15.6.7 Thermo Fisher Scientific, Inc.
    • 15.6.8 Sysmex Corporation.
    • 15.6.9 Trivitron Healthcare.
    • 15.6.10 Koninklijke Philips N.V.

16. Strategic Recommendations